The mechanism of 3'-azido-2',3'-dideoxythymidine resistance to human lymphoid cells. 2003

Gerold Hoever, and Bettina Groeschel, and Prakash Chandra, and Hans W Doerr, and Jindrich Cinatl
Institute of Medical Virology, Johann Wolfgang Goethe-University Frankfurt, D-60596 Frankfurt/Main, Germany.

The human T-lymphoid cell line H9 resistant to 3'-azido-2',3'-dideoxythymidine (AZT) has a very low level of thymidine kinase (TK) expression which accounts for the failure of AZT to inhibit HIV-1 replication. In the present study DNA methylation and histone deacetylation as possible mechanisms of decreased TK gene expression in the resistant cells were investigated. The resistant cells expressed high levels of DNA methyltransferases (DNMTs) 3a and 3b. The DNA methylation inhibitor, 5-aza-cytidine (5-aza-C), increased TK gene expression and antiviral activity of AZT in the resistant cells, while histone deacetylase inhibitor trichostatin A (TSA) had no effect. The results suggest that hypermethylation of the TK gene but not histone deacetylation in AZT-resistant H9 cells accounts for decreased TK gene expression and failure of AZT to inhibit HIV-1 replication probably due to overexpression of DNMT 3a and 3b.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090205 DNA Methyltransferase 3A A methyltransferase that catalyzes the addition of a methyl group to CYTOSINE residues of CpG dinucleotides and is required for genome-wide de novo DNA METHYLATION. DNA Methyltransferase 3 alpha,DNMT3A Protein,3A, DNA Methyltransferase,Methyltransferase 3A, DNA,Protein, DNMT3A
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D013937 Thymidine Kinase An enzyme that catalyzes the conversion of ATP and thymidine to ADP and thymidine 5'-phosphate. Deoxyuridine can also act as an acceptor and dGTP as a donor. (From Enzyme Nomenclature, 1992) EC 2.7.1.21. Deoxythymidine Kinase,Deoxypyrimidine Kinase,Kinase, Deoxypyrimidine,Kinase, Deoxythymidine,Kinase, Thymidine
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

Gerold Hoever, and Bettina Groeschel, and Prakash Chandra, and Hans W Doerr, and Jindrich Cinatl
December 1999, Molecular pharmacology,
Gerold Hoever, and Bettina Groeschel, and Prakash Chandra, and Hans W Doerr, and Jindrich Cinatl
August 2004, Antiviral research,
Gerold Hoever, and Bettina Groeschel, and Prakash Chandra, and Hans W Doerr, and Jindrich Cinatl
May 1997, Mutation research,
Gerold Hoever, and Bettina Groeschel, and Prakash Chandra, and Hans W Doerr, and Jindrich Cinatl
July 2002, Biochemical pharmacology,
Gerold Hoever, and Bettina Groeschel, and Prakash Chandra, and Hans W Doerr, and Jindrich Cinatl
January 1988, Annals of neurology,
Gerold Hoever, and Bettina Groeschel, and Prakash Chandra, and Hans W Doerr, and Jindrich Cinatl
April 1989, The Journal of biological chemistry,
Gerold Hoever, and Bettina Groeschel, and Prakash Chandra, and Hans W Doerr, and Jindrich Cinatl
April 1992, British journal of haematology,
Gerold Hoever, and Bettina Groeschel, and Prakash Chandra, and Hans W Doerr, and Jindrich Cinatl
March 2012, Medicinal chemistry (Shariqah (United Arab Emirates)),
Gerold Hoever, and Bettina Groeschel, and Prakash Chandra, and Hans W Doerr, and Jindrich Cinatl
January 1987, Molekuliarnaia biologiia,
Gerold Hoever, and Bettina Groeschel, and Prakash Chandra, and Hans W Doerr, and Jindrich Cinatl
November 1995, International journal of oncology,
Copied contents to your clipboard!